The US Department of Defense (DoD) has awarded a contract to Pall Corporation for new breathing filter manufacturing line.

The new line will be built at the company’s facility in the US to meet the demand of ventilator filters amid the coronavirus (Covid-19) pandemic.

Under the $4.9m valued contract, the new line will increase the production of ventilator filters from 485,000 units per month to 650,000 units per month.

The new line is expected to commence operations next year.

The DoD funding will support an increase in suppliers’ capacity for domestic ventilator critical components.

Pall Corporation and Danaher Group Executive president Jennifer Honeycutt said: “We are proud Pall was awarded this DoD contract, which allows us to increase the production of ventilator filters to help protect patients and give health care workers the equipment needed in a pandemic situation.”

Additionally, Pall’s lab solutions are supporting Covid-19 research and vaccine production processes.

Pall is a member of the Oxford University-led consortium working on developing an ‘effective Covid-19 vaccine’.

Honeycutt added: “From the start of the Covid-19 crisis, Pall has drawn on the depth and breadth of our material science and engineering expertise across a wide range of industries to devise trusted solutions that support research, help patients heal and eliminate the spread of this disease.

“It’s through our innovation that we will continue to apply our expertise in novel ways to protect people around the world.”